Literature DB >> 10986027

The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study.

J S Lindholt1, S Vammen, H Fasting, E W Henneberg, L Heickendorff.   

Abstract

OBJECTIVES: increased levels of various proteinases have been detected in abdominal aortic aneurysms (AAA) and are assumed to cause the degradation of the aortic wall. To determine whether systemic measurement of these proteinases and their inhibitors may predict the natural cause of AAA. METHODS AND MATERIAL: serum (S) and plasma (P) samples were obtained from 121 men following the diagnosis of a small AAA (3-5 cm) at population screening. Annual control scans were performed to check for expansion. Circulating levels of elastase-alpha 1 antitrypsin-complexes, alpha 1 antitrypsin, matrix metalloproteinase (MMP) 2 & 9, tissue-inhibitor-matrixproteinase 1 & 2, procollagen III-N-terminal-propeptide, and elastin-peptides were measured in a random group of 36 men.
RESULTS: alpha 1 antitrypsin was significantly and positively associated with expansion. Similarly, P-MMP9 levels were significantly associated with size and expansion. There was a difference between median serum and plasma values, probably because of secretion from platelets.
CONCLUSION: P-MMP9 and P-alpha 1 antitrypsin may predict the natural history of AAA. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986027     DOI: 10.1053/ejvs.2000.1151

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  25 in total

1.  RGD-conjugated human ferritin nanoparticles for imaging vascular inflammation and angiogenesis in experimental carotid and aortic disease.

Authors:  Toshiro Kitagawa; Hisanori Kosuge; Masaki Uchida; Monica M Dua; Yasunori Iida; Ronald L Dalman; Trevor Douglas; Michael V McConnell
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

2.  Integrin-targeted molecular imaging of experimental abdominal aortic aneurysms by (18)F-labeled Arg-Gly-Asp positron-emission tomography.

Authors:  Toshiro Kitagawa; Hisanori Kosuge; Edwin Chang; Michelle L James; Tomoaki Yamamoto; Bin Shen; Frederick T Chin; Sanjiv S Gambhir; Ronald L Dalman; Michael V McConnell
Journal:  Circ Cardiovasc Imaging       Date:  2013-08-30       Impact factor: 7.792

Review 3.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

4.  Aortic dimensions and the risk of dissection.

Authors:  Raimund Erbel; Holger Eggebrecht
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

Review 5.  Biomarkers of AAA progression. Part 1: extracellular matrix degeneration.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-05-26       Impact factor: 32.419

6.  Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm.

Authors:  Kin Lung Siu; Hua Cai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

7.  Can local secretion of prostaglandin E2, thromboxane B2, and interleukin-6 play a role in ruptured abdominal aortic aneurysm?

Authors:  Bernice L Y Cheuk; Stephen W K Cheng
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

8.  Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction.

Authors:  Takayuki Fujiwara; Toshiro Matsunaga; Kunihiko Kameda; Naoki Abe; Hirotsugu Ono; Takumi Higuma; Jin Yokoyama; Hiroyuki Hanada; Tomohiro Osanai; Ken Okumura
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

Review 9.  Ultrasonographic screening for the detection of abdominal aortic aneurysms.

Authors:  Hans-Henning Eckstein; Dittmar Böckler; Ingo Flessenkämper; Thomas Schmitz-Rixen; Sebastian Debus; Werner Lang
Journal:  Dtsch Arztebl Int       Date:  2009-10-09       Impact factor: 5.594

10.  Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm.

Authors:  Bernd Muehling; Alexander Oberhuber; Hubert Schelzig; Gisela Bischoff; Nikolaus Marx; Ludger Sunder-Plassmann; Karl H Orend
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.